ARIALYS Trademark

Trademark Overview


On Tuesday, December 9, 2025, a trademark application was filed for ARIALYS with the United States Patent and Trademark Office. The USPTO has given the ARIALYS trademark a serial number of 99538517. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 28, 2026. This trademark is owned by Arialys Therapeutics, Inc.. The ARIALYS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Allergy relief medication; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antibiotics; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating asthma; pharmaceutical agents for epidermis; anesthetics for surgical use; cardiovascular pharmaceutical preparations; pharmaceutical products for the treatment of infectious diseases; pharmaceutical agents affecting sensory organs; antiallergic medicines; pharmaceutical preparations for peripheral nervous system; medicines for dental purposes; pharmaceutical agents affecting digestive organs; eye drops; ear drops; nasal sprays for medical purposes; medical preparation for slimming purposes; pharmaceutical products for the treatment of cancer; pharmaceutical prep...

Research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; chemical analysis; bacteriological research; biological research; Medical and scientific research in the nature of conducting clinical trials for others; scientific research; scientific laboratory services
arialys

General Information


Serial Number99538517
Word MarkARIALYS
Filing DateTuesday, December 9, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 28, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2026

Trademark Statements


Goods and ServicesAllergy relief medication; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antibiotics; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating asthma; pharmaceutical agents for epidermis; anesthetics for surgical use; cardiovascular pharmaceutical preparations; pharmaceutical products for the treatment of infectious diseases; pharmaceutical agents affecting sensory organs; antiallergic medicines; pharmaceutical preparations for peripheral nervous system; medicines for dental purposes; pharmaceutical agents affecting digestive organs; eye drops; ear drops; nasal sprays for medical purposes; medical preparation for slimming purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; tumor suppressing agents; pain relief medication; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for treating hypertension; anaesthetics; alcohol for pharmaceutical purposes; diagnostic reagents for medical use; capsules sold empty for pharmaceuticals; dietetic preparations adapted for medical purposes; adhesive plasters for medical purposes; medical dressings; teeth filling material; lacteal flour for babies; nutritional supplements; baby food; dietary supplements for animals; semen for artificial insemination
Goods and ServicesResearch in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; chemical analysis; bacteriological research; biological research; Medical and scientific research in the nature of conducting clinical trials for others; scientific research; scientific laboratory services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 9, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 9, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArialys Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
US

Trademark Events


Event DateEvent Description
Tuesday, December 9, 2025NEW APPLICATION ENTERED
Tuesday, December 9, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 14, 2026ASSIGNED TO EXAMINER
Tuesday, April 14, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 14, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, April 14, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 14, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, April 21, 2026APPROVED FOR PUB - PRINCIPAL REGISTER